Maternal lipopolysaccharide-induced inflammation during pregnancy programs impaired offspring innate immune responses

Ron Beloosesky1, Nir Maravi, Zeev Weiner

  • 1Department of Obstetrics/Gynecology, Rambam Medical Center, Haifa, Israel. tomor2304@yahoo.com

Insights

Maternal exposure to lipopolysaccharides during pregnancy suppresses the offspring's innate immune response. This suggests prenatal inflammation may increase a newborn's susceptibility to infections.

Area of Science:

  • Immunology
  • Developmental Biology
  • Perinatal Medicine

Background:

  • The fetal immune system matures during gestation, with early inflammatory pathway activation potentially impacting immune competency.
  • Understanding the long-term effects of prenatal inflammatory exposures is crucial for neonatal health.

Purpose of the Study:

  • To investigate the impact of maternal lipopolysaccharide exposure on the developing fetal immune system.
  • To determine if prenatal inflammation affects the innate immune response of offspring to inflammatory stimuli.

Main Methods:

  • Pregnant rats received lipopolysaccharides or saline solution at 18 days gestation.
  • Offspring were assessed at postnatal day 24 for plasma cytokine levels following lipopolysaccharide challenge.
  • Key cytokines measured included interleukin-6, interleukin-1beta, tumor necrosis factor-alpha, and interleukin-10.

Main Results:

  • Offspring of dams exposed to lipopolysaccharides showed significantly reduced levels of interleukin-6, interleukin-1beta, tumor necrosis factor-alpha, and interleukin-10.
  • This indicates a suppressed innate immune response in pups exposed to prenatal inflammation.

Conclusions:

  • Maternal lipopolysaccharide exposure during pregnancy suppresses the innate immune response of offspring.
  • Prenatal inflammatory exposures may impair neonatal immune defenses, increasing vulnerability to infections.
Abstract